FDA NDC Directory · JSON-LD · Markdown

signature care acid reducer

NDC 21130-181 · HUMAN OTC DRUG · CAPSULE, DELAYED RELEASE

Generic nameLansoprazole
Labeler / ManufacturerSafeway
Marketing categoryAbbreviated NDA (generic) · App ANDA202319
Dosage form / routeCAPSULE, DELAYED RELEASE · ORAL
Active ingredientsLANSOPRAZOLE (15 mg/1)
Marketing started20150927
Package count2

External sources

Source: openFDA. Public-domain (CC0).